Abstract |
A prospective, controlled, randomised, double-blind trial suggested that: 1. The use of bupivacaine 0.5% plain and prilocaine 3% with felypressin 0.03 i.u./ml. as peroperative local analgesics reduce postoperative pain scores recorded on the first postoperative morning (P less than 0.05). 2. Bupivacaine 0.5% plain reduces postoperative opiate requirements (P less than 0.025). 3. Patients do not find peroperative bilateral inferior alveolar and lingual nerve blocks with buccal infiltrations significantly unpleasant. Thus peri-operative bupivacaine 0.5% is a valuable adjunct to third molar removal under general anaesthesia.
|
Authors | J R Tuffin, D R Cunliffe, S R Shaw |
Journal | The British journal of oral & maxillofacial surgery
(Br J Oral Maxillofac Surg)
Vol. 27
Issue 1
Pg. 27-32
(Feb 1989)
ISSN: 0266-4356 [Print] Scotland |
PMID | 2645933
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Analgesics
- Prilocaine
- Bupivacaine
|
Topics |
- Adolescent
- Adult
- Analgesics
(administration & dosage)
- Anesthesia, Dental
- Anesthesia, General
- Bupivacaine
(administration & dosage)
- Clinical Trials as Topic
- Double-Blind Method
- Female
- Humans
- Intraoperative Care
- Male
- Molar, Third
(surgery)
- Pain, Postoperative
(prevention & control)
- Prilocaine
(administration & dosage)
- Prospective Studies
- Random Allocation
- Tooth Extraction
|